• News
  • Anal Cancer
  • Bladder Cancer
  • Bone Cancer
  • Brain Cancer
  • Breast Cancer
  • Cancer of Unknown Primary
  • Cervical Cancer
  • Colon Cancer
  • Esophageal Cancer
  • Gastric Cancer
  • GIST
  • Head & Neck Cancer
  • Hodgkins Lymphoma
  • Leukemia
    • Acute Leukemia
    • Chronic Lymphocytic Leukemia
    • Chronic Myeloid Leukemia
  • Liver Cancer
  • Lung Cancer
  • Melanoma
  • Mesothelioma
  • Multiple Myeloma
  • Myelodysplastic Syndrome
  • MPN-PV-ET-MF
  • Neuroblastoma
  • Neuroendocrine Tumors
  • Non Hodgkins Lymphoma
  • Ovarian Cancer
  • Pancreatic Cancer
  • Prostate Cancer
  • Renal Cancer
  • Rectal Cancer
  • Sarcoma
  • Skin Care
  • Skin Cancer
  • Testicular Cancer
  • Thyroid Cancer
  • Triple Negative Breast Cancer
  • Uterine Cancer
  • About Us
  • Advertising
  • News
  • Newly Diagnosed
  • Treatment & Care
  • Survivorship
  • Join the Community
  • Newsletter

Breast Cancer Treatment

  • Understanding Surgery for Breast Cancer
    September 1, 2025

    Understanding Surgery for Breast Cancer

    Charles H. Weaver, MD
  • Side Effects and New CDK Inhibitor Class of Breast Cancer Drugs
    August 29, 2025

    Side Effects and New CDK Inhibitor Class of Breast Cancer Drugs

    Charles H. Weaver, MD
  • Oncotype Recurrence Score Test-What You Need to Know
    August 29, 2025

    Oncotype Recurrence Score Test-What You Need to Know

    Charles H. Weaver, MD
  • Endocrine – Hormone Therapy for Early Stage Breast Cancer
    August 27, 2025

    Endocrine – Hormone Therapy for Early Stage Breast Cancer

    Charles H. Weaver, MD
  • Breast Cancer Overview
    June 4, 2025

    Breast Cancer Overview

    Charles H. Weaver, MD
  • Early Study Demonstrates Patritumab Deruxtecan Activity in Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
    April 1, 2025

    Early Study Demonstrates Patritumab Deruxtecan Activity in Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer

    Charles H. Weaver, MD
  • Breast Cancer – Are You Aware?
    September 30, 2023

    Breast Cancer – Are You Aware?

    Charles H. Weaver, MD
  • Patritumab Deruxtecan Shows Promise in HER3-Expressing Metastatic Breast Cancer
    August 31, 2023

    Patritumab Deruxtecan Shows Promise in HER3-Expressing Metastatic Breast Cancer

    Charles H. Weaver, MD
  • CA 15-3 Breast Tumor Marker
    April 5, 2023

    CA 15-3 Breast Tumor Marker

    Charles H. Weaver, MD
  • Elacestrant Hormone Therapy for Advanced Breast Cancer
    March 1, 2022

    Elacestrant Hormone Therapy for Advanced Breast Cancer

    Charles H. Weaver, MD
  • Ki 67 Biomarker and Breast Cancer
    October 25, 2021

    Ki 67 Biomarker and Breast Cancer

    Charles H. Weaver, MD
  • Hispanic Women Speak Out About Breast Cancer
    March 7, 2020

    Hispanic Women Speak Out About Breast Cancer

    Charles H. Weaver, MD
1 2
Next Page
  • Sitemap
  • About Us
  • Advertising
  • Privacy Policy
 

Loading Comments...